A Senate hearing focused on China's threat to American seniors through drug supply chains, financial scams, and data privacy, with lawmakers calling for a serious national security response to reduce U.S. dependence on Chinese pharmaceutical ingredients.
The reliance on China for critical pharmaceutical ingredients raises national security concerns, potentially impacting the health and security of millions of Americans, particularly seniors.
A U.S. Senate hearing on Wednesday highlighted concerns that China poses a threat to American senior citizens through its dominance in drug supply chains, financial scams, and data privacy issues. Lawmakers and witnesses described the situation as a national security concern, urging the U.S. to reduce its dependence on China.
Senator Rick Scott, a Republican from Florida, stated that the U.S. needed to "get serious" about the issue, drawing a comparison to the limited access granted to the Soviet Union fifty years ago. He noted that China supplies a significant portion of the active pharmaceutical ingredients (APIs) for U.S. antibiotics, citing figures of 87% for antibiotics and 80-90% for global API production.
Chris Slevin, representing the U.S.-China Economic and Security Review Commission (USCC), testified that China's "weaponization of supply chains is not theoretical" and that controlling global supply chains is an explicit strategic goal for the country. The hearing, titled “Counting the Cost: Communist China’s Toll on Older Americans’ Health, Finances and Security,” featured four witnesses from the USCC, a bipartisan congressional panel established to scrutinize China.